亚托皮性皮肤炎全身治疗的决策因素:临床审查
Jasmine Levine1, Apoorva Mehta1, Ross O'Hagan1
1From the Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Dermatitis : contact, atopic, occupational, drug
|March 2, 2026
概括
亚托匹性皮肤炎的治疗已经演变为向生物药物和JAK抑制剂. 生物药物提供持久的控制和安全性,而JAK抑制剂提供快速的缓解,指导个性化治疗选择.
科学领域:
- 皮肤病学 皮肤病学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 亚托皮炎 (AD) 是一种慢性炎症性皮肤疾病,影响生活质量.
- 最近的进展包括针对性生物制剂和小分子疗法,用于2型炎症和.
研究的目的:
- 审查目前关于生物药物和亚努斯激酶抑制剂 (JAKis) 对亚托皮炎的证据.
- 概述针对个性化治疗选择的疗效,安全性和实际决策因素.
主要方法:
- 关于生物制剂和AD中的JAKis当前证据的叙述性综述.
- 综合了关于疗效,安全性和以患者为中心的因素的数据.
主要成果:
- 美国食品和药物管理局批准的生物制剂 (杜皮卢马布,特拉洛基努马布等) 显示有效性和安全性.
- 口服的JAKs (阿布罗西提尼布,阿帕达西提尼布等) 提供快速控制,但有黑盒警告.
- 比较试验表明,使用JAKis可以更快地缓解,而使用生物药物可以持续控制和安全.
结论:
- 个性化治疗选择至关重要,考虑到患者的因素 (年龄,并发症,风险) 和偏好 (剂量,管理).
- 在治疗决策中,获取和负担能力是关键考虑因素.
- 未来的研究应该专注于比较研究,生物标志物和公平获得先进的AD疗法.
相关概念视频
Factors Affecting Drug Response: Overview
3.2K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
3.2K
Drugs Used in Lower Respiratory Disorders: Overview
1.3K
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.3K
Asthma: Pathogenesis and Management
1.5K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.5K
Hypersensitivities
8.0K
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
8.0K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
2.1K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.1K
Inflammatory Bowel Disease IV: Pharmacological Management
868
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
868


